Yogurt consumption can help lower blood pressure in older adults with elevated levels, according to a new study led by an international team, including researchers at the University of Maine.
The study, a new finding in the Maine-Syracuse Longitudinal Study (MSLS), was conducted by researchers Alexandra Wade of the University of South Australia, and UMaine researchers Benjamin Guenther, Fayeza Ahmed and Merrill “Pete” Elias, and was published in the International Dairy Journal.
Cardiovascular disease is the leading cause of death, and high blood pressure is a leading risk factor for cardiovascular disease, stroke and diabetes. Diet has long been suggested as a means of lowering blood pressure levels and diets to improve health are very popular.
The MSLS team examined the relationship between yogurt consumption and blood pressure among older adults with and without high blood pressure. Researchers analyzed cross-sectional data for 915 adults (average age 62.1 years) from the Maine-Syracuse Longitudinal Study. Approximately 62% of the sample had high blood pressure as defined as 140/90 mmHg.
Statistical analyses revealed modest but statistically significant reductions in systolic blood pressure among those with high blood pressure who consumed yogurt, according to UMaine, in a news release.
The MSLS study was the first to ask whether yogurt reduces blood pressure for persons who exhibit normal BP levels, according to the researchers. There was no improvement associated with eating yogurt in individuals with normal blood pressure.
The findings were before and after adjusting for the confounding by many other variables known to influence blood pressure, such as age, gender, education, diabetes, body mass index, cholesterol, blood sugar levels, exercise and other dietary variables.
Previous work by the MSLS investigators indicated a positive association between Mediterranean Diet and better cognitive function, and between other dairy products and lowering of blood pressure in persons free from history of stroke and kidney disease.
MSLS, focused on aging, hypertension, cardiovascular disease and cognitive function, was launched in 1974 at Syracuse University by Elias and continued at the University of Maine for over 40 years. It has obtained longitudinal and cross-sectional data from young adulthood to the elder years for 1,000 individuals, and cross-sectional data for more than 2,400 individuals initially recruited from central New York and followed throughout the U.S.
Data collection has been supported by numerous grants from the National Heart, Lung, the National Institute on Aging, and travel grants from NATO and the University of South Australia.
Ahmed is MSLS associate director; Guenther serves as the UMaine statistician for MSLS; Elias is MSLS director; Wade is an MSLS collaborator. More information about MSLS is available online or by contacting Ahmed, firstname.lastname@example.org.
About the University of Maine:
The University of Maine, founded in Orono in 1865, is the state's land grant, sea grant and space grant university. It is located on Marsh Island in the homeland of the Penobscot Nation. As Maine's flagship public university, UMaine has a statewide mission of teaching, research and economic development, and community service. UMaine is the state's only public research university and among the most comprehensive higher education institutions in the Northeast. It attracts students from all 50 states and more than 75 countries. UMaine currently enrolls 11,741 undergraduate and graduate students who have opportunities to participate in groundbreaking research with world-class scholars. UMaine offers more than 100 degree programs through which students can earn master's, doctoral or professional science master's degrees, as well as graduate certificates. The university promotes environmental stewardship, with substantial efforts campuswide to conserve energy, recycle and adhere to green building standards in new construction. For more information about UMaine, visit umaine.edu.